FDA to Pay Bonuses for Faster Drug Reviews, Sparking Debate
The FDA is piloting cash bonuses to reward reviewers who finish drug evaluations faster while preserving scientific r...
Tax-efficient bond funds minimize distributions and turn over smaller tax liabilities, helping maintain after-tax returns during retirement.
24,393 articlesThe FDA is piloting cash bonuses to reward reviewers who finish drug evaluations faster while preserving scientific r...
DSGR's Q4 2025 results sparked questions about growth, margins, and 2026 guidance. This deep dive explains what the n...
A widening Iran conflict threatens energy supplies and household budgets, prompting new warnings that the crisis coul...
As rates cool, Angel Oak’s Hutchens charts a growth path for non-QM lending with a sharper focus on product expansion...
XRP/BTC is flashing a major warning as the pair struggles under key moving averages and tests vital support, keeping ...
A new leadership playbook is on the table at Target. This article breaks down five actionable takeaways from the late...
XRP is slipping again as macro risk-off tones and a large pool of underwater holders keep a lid on rallies. Analysts ...
Universal Corp misses EPS and swings to a loss in the third quarter, triggering a double-digit stock drop. Analysts f...
Investors are weighing three very different tech names as AI upgrades drive Nvidia higher while Qualcomm faces a toug...
A California jury confronts a high-stakes question: can the way social apps are built cause harm to young users? The ...
A big bet on a digital banking stock can signal confidence in transformation, but a 30% drop demands careful scrutiny...
XRP is testing critical levels near $1.40 this week as traders watch for a breakout. Momentum is building, but regula...